Drug-induced fever can complicate antibiotic treatment and lead to unnecessary testing when cultures are negative, and ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

Urinary tract infections (UTIs) commonly occur in people who undergo chemotherapy. The treatment can weaken the immune system and damage barriers, such as the skin and mucous membranes, that help ...

A GSK pill that offers a lower potential for drug resistance is now FDA approved as a new treatment for a common type of urinary tract infection, the first new oral antibiotic for this indication in ...

Good news for the millions of women who struggle with urinary tract infections (UTIs). The Food and Drug Administration (FDA) has approved a new drug, Blujepa, the first of a new class of oral ...

Pivmecillinam has been used for decades in Europe and may work for UTIs that don’t respond to other antibiotics. Urinary tract infections are one of the most common reasons for antibiotic use.

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is “first-in-its-class”, which means it uses a unique mechanism to treat UTIs, ...

Five months after signing off on Utility Therapeutics’ Pivya as the first new treatment for uncomplicated urinary tract infections (uUTIs) in more than two decades, the FDA is weighing the pros and ...

Researchers from the University of Colorado Anschutz Medical Campus studied a new method to deliver antibiotics, specifically gentamicin, directly into the bladder tissue to better treat UTIs. They ...

Not only can this cause dryness and discomfort, the urethra sometimes doesn’t seal properly, and bacteria can get into the ...